Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

US10253003B2 · kind B2 · utility

Assignee

• Janssen Sciences Ireland UC · IE

Inventors

• Stefaan Julien Last · Lint, BE
• David Craig McGowan · Vilvoorde, BE
• Werner Constant Johan Embrechts · Beerse, BE
• Serge Maria Aloysius Pieters · Wichelen, BE
• Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
• Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

• Filing date: May 10, 2017
• Grant date: Apr 9, 2019
• Expiry date: May 10, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This invention relates to heterocyclic substituted 2-amino-quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.